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Abstract  
Objective 
We analysed the correlation between magnetic resonance images of the parotid and 
submandibular glands and the salivary flow rate in patients with Sjögren's syndrome.  
Methods 
We retrospectively reviewed magnetic resonance images (heterogeneous signal-intensity 
distribution and gland volume on T1- and fat-suppressed T2-weighted images, and multiple 
high-signal-intensity spots on magnetic resonance sialograms in the parotid and 
submandibular glands) obtained from 66 patients who were diagnosed with Sjögren’s 
syndrome. We evaluated the relationship between these imaging features and their salivary 
flow rates in stimulated and unstimulated conditions. 
Results 
We found that, as the disease progressed, both the heterogeneous signal-intensity distribution 
and the volumes of the parotid and the submandibular glands were significantly related to the 
stimulated and the unstimulated salivary flow rate. These imaging features were more highly 
correlated in assessments of the submandibular gland than in those of the parotid gland for 
both stimulated and unstimulated salivary flow rates. 
Conclusions 
Magnetic resonance image features of heterogeneity and smaller volume in the 
submandibular gland are reliable for predicting hyposalivation related to the progression of 
Sjögren’s syndrome. 
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Introduction  
Destruction of the acinar tissues of salivary glands in patients with Sjögren’s syndrome (SS) 
result in hyposalivation, i.e., a reduction in salivary flow rate (Bloch et al., 1965; Kohler & 
Winter, 1985; Manthorpe, 2002). Salivary gland scintigraphy, which is a commonly used 
diagnostic imaging modality for assessing salivary gland function, has indicated that 
scintigraphic features correlated well both with the histopathological findings of labial gland 
biopsies and a reduction in parotid flow rate in SS patients (Daniels et al., 1979). Other 
researchers using salivary gland scintigraphy have noted that, as the disease progresses, the 
submandibular gland exhibits greater dysfunction than the parotid gland in SS patients 
(Umehara et al., 1999; Aung et al., 2000; Tonami et al., 2001; Aksoy et al., 2012). 
Characteristic magnetic resonance (MR) imaging features of the parotid gland in SS patients 
include heterogeneous signal-intensity distribution (HD) on T1- and T2-weighted images 
(“salt and pepper appearance”) (Izumi et al., 1996; Vogl et al., 1996) and multiple 
high-signal-intensity spots (MHS) on MR sialograms (“apple tree appearance”) (Ohbayashi et 
al., 1998; Tonami et al., 1998). The HD represents histopathological destruction of acinar 
tissue with fat tissue infiltration, while the MHS, which mostly comprised saliva leaked from 
peripheral ducts, represent ductal abnormalities (Garrett, 1962; Izumi et al., 1997; Niemela et 
al., 2001). Previous reports also demonstrated that the HD in the parotid gland was related to 
the salivary flow rate (Izumi et al., 1997), while the MHS were not related to the salivary flow 
rate on MR sialograms of parotid glands (Niemela et al., 2001). However, these studies did 
not investigate the submandibular gland. We recently reported that (1) the presence of MHS 
on MR sialograms and HD on both T1- and fat-suppressed T2-weighted MR images had 
higher specificity for the submandibular gland than for the parotid gland in patients with SS, 
and that (2) the submandibular gland volume, but not the volume of parotid or sublingual 
glands, appeared smaller in SS patients (Kojima et al., 2017). Consequently, we concluded 
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that such specific changes in the submandibular gland were helpful in assessing SS patients, 
particularly in advanced cases. Additionally, physiological evidence has shown that more than 
65% of unstimulated whole saliva is produced by the submandibular gland, while the parotid 
gland contributes approximately 20%, despite its massive size (Sreebny, 2010). This 
background information prompted us to hypothesise that MR imaging of the submandibular 
gland might closely correlate with hyposalivation as the disease progresses. No studies, 
however, have focused on the correlation between MR imaging of the submandibular gland 
and corresponding salivary flow rate in SS patients. We, therefore, retrospectively 
investigated the relationship between MR imaging of the submandibular gland and the 
corresponding salivary flow rate in SS patients, in comparison with the parotid gland. 
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Methods 
Our retrospective study was performed in accordance with the Declaration of Helsinki, and 
was approved by the Institutional Review Board (Tohoku University Graduate School of 
Dentistry, No. 2017-3-22).  
 
Patients 
Sixty-six patients (two males and 64 females; age range, 19–79 years old; mean age, 54 
years) with SS participated in this study. Diagnosis of SS was determined by xerostomia as 
the chief complaint, along with positive anti-SS-A and/or anti-SS-B antibodies in serological 
tests, and focal lymphocytic sialadenitis in histopathological assessment of labial gland 
biopsy. A focal score of ≥1 was defined as positive, in accordance with the histopathology 
criteria of Greenspan et al. (1974). These patients were subsequently definitively diagnosed 
with SS, in accordance with the criteria proposed by the American College of Rheumatology 
(Shiboski et al., 2012), as well as the Japanese criteria (Fujibayashi et al., 2004). Human 
immunodeficiency virus and sarcoidosis were excluded in all patients upon evaluation by 
autoimmune disease specialists.  
 
Collection of stimulated and unstimulated saliva 
Patients were instructed to do nothing to stimulate the flow of saliva for at least 90 min 
before the collection time. This included tooth brushing, using mouthwash, drinking, chewing, 
and smoking. Stimulated salivary flow rate was determined using the gum test (Fujibayashi et 
al., 2004): patients chewed a polyvinyl acetate gum and collected their saliva into a vessel for 
10 min. Unstimulated salivary flow rate was tested using the spitting method (Speight et al., 
1992; Marton et al., 2008): patients expectorated their saliva for 15 min into a vessel while 
making as few movements as possible during the procedure. A decrease of salivation was 
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defined as a flow rate of < 10 mL/10 min for stimulated saliva (Fujibayashi et al., 2004) or < 
1.5 mL/15 min (Speight et al., 1992; Marton et al., 2008) for unstimulated saliva. 
 
MR imaging technique 
MR examination was performed by a 1.5- or 3.0-Tesla MR imager (Achieva 1.5T or Achieva 
3.0T; Royal Philips Electronics, Eindhoven, the Netherlands) with surface coils. We obtained 
spin-echo transverse T1-weighted images (repetition time/echo time, 477–619/7–12 ms), fast 
spin-echo transverse fat-suppressed T2-weighted images (repetition time/echo time, 4000–
5711/54–90 ms), and high-resolution 3D-MR sialograms (repetition time/echo time/number 
of signal-intensity acquisitions, 5000/602–675 ms/2), using the same methods (Kojima et al., 
2017). T1- and fat-suppressed T2-weighted images were collected using 5-mm section 
thickness with a 1 mm intersection gap, acquisition matrix of 512 × 358, and FOV of 210 mm. 
Three-dimensional MR sialograms comprised 1 mm with a gapless acquisition, acquisition 
matrix of 512 × 512, and FOV of 200 mm, and used a heavily T2-weighted fast spin-echo 
sequence, based on a previous report. This 3D technique of the MR sialogram has been 
excellent for detecting fine salivary gland ducts and small abnormalities (Sakamoto et al., 
2001). The MR sialograms consisted of 20-slice images. 
 
MR Imaging analysis 
We exported all MR images as Digital Imaging and Communications in Medicine (DICOM) 
files and imported them into specially designed DICOM viewing software (Aquarius NET; 
TeraRecon, Foster City, CA, USA); all MR images were separated from clinical information. 
Two board-certified oral and maxillofacial radiologists (I.K. and M.S., with 13 and 33 years 
of experience, respectively) independently reviewed random-ordered MR images under the 
condition that they could not know any clinical information except that the MR images were 
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obtained from patients with a definite diagnosis of SS, on the basis of the criteria described in 
the “Patients” subsection (above). The reviewers evaluated (i) HD on T1- and fat-suppressed 
T2-weighted images, (ii) MHS on MR sialograms and (iii) the volumes of each respective 
major salivary gland. We estimated the parotid and submandibular glands, but not the 
sublingual gland, in the present study, because the sublingual gland has demonstrated low 
diagnostic value in diagnosing SS on MR imaging (Kojima et al., 2017). (i) We graded the 
HD depending on the degree of the acinar tissue destruction with fat tissue infiltration, which 
was previously reported to demonstrate a heterogeneous distribution of very high 
signal-intensity on T1-weighted images and very low signal-intensity on fat-suppressed 
T2-weighed images (Izumi et al., 1996; Izumi et al., 1997). We excluded microcysts, 
observed as high-signal-intensity spots on fat-suppressed T2-weighted images, from the HD 
grading, as microcysts are closely related to the MHS. HD was assessed as grade 0 (definitely 
normal: homogeneous), 1 (probably normal: almost homogeneous), 2 (probably abnormal: 
slightly heterogeneous), 3 (clearly abnormal: moderately heterogeneous), and 4 (definitely 
abnormal: severely heterogeneous) by the objective evaluation of the radiologists (Figure 1). 
We assessed severely atrophied glands which had almost been displaced by fat tissue as grade 
4 (severe heterogeneous). (ii) By using X-ray sialography criteria established in previous 
reports, we graded the MHS on the basis of the size of the high-signal-intensity spots, which 
were composed of saliva leaked from peripheral ducts (Niemela et al., 2001). MHS was 
assessed as stage 0 (no cavities found), 1 (cavities ≤ 1 mm in diameter), 2 (cavities 1–2 mm 
in diameter), 3 (cavities > 2 mm in diameter), and 4 (severe irregular dilatation of the main 
duct with bizarrely patterned cavities). (iii) The volume of the salivary glands was measured, 
as previously reported (Ono et al., 2006; Kojima et al., 2017). The parotid and submandibular 
gland volumes were calculated as the sum of all transverse section areas, multiplied by 
section thickness. Reviewers resolved disagreements of grading and staging by discussion. 
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Statistical analysis 
The relationships between the HD grade or MHS stage and the salivary flow rate were 
analysed using the Kruskal-Wallis rank sum test. For multiple comparisons, the Steel-Dwass 
method was used in further investigation. Correlations between the salivary gland volume 
and the salivary flow rate were tested by Spearman’s rank correlation coefficient (ρ). The 
strength of correlation was classified as negligible or no correlation (|ρ| ≤ 0.20), weak (|ρ| = 
0.21 to 0.40), moderate (|ρ| = 0.41 to 0.70), or strong (|ρ| = 0.71 to 1.00). We analysed 
diagnostic performance and cut-off values for diagnosing hyposalivation by using receiver 
operating characteristic (ROC) curve analysis. Diagnostic performance was evaluated 
between the parotid and submandibular glands by comparing sensitivity, specificity, area 
under the ROC curve (AUC) and its 95% confidence interval (95%CI). P-values of < 0.05 
were defined as significantly different. We measured kappa coefficient (ƙ) of interobserver 
agreement between the two reviewers for grading and staging in the imaging analysis. The ƙ 
value of 0.01 to 0.20 indicated slight; 0.21 to 0.40, fair; 0.41 to 0.60, moderate; 0.61 to 0.80, 
substantial; 0.81 to 1.00, excellent agreement. For statistical analysis, we used EZR software 
(Saitama Medical Center, Jichi Medical University), which provides a graphical interface for 
R (version 2.13.0; The R Foundation for Statistical Computing, Vienna, Austria). 
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Results 
Salivary flow rate 
Forty-two of the 66 patients with SS (63.6%) showed decreased salivation in the stimulated 
salivary flow rate test (< 10 mL/10 min) and 44 (66.7%) showed a decreased unstimulated 
salivary flow rate (< 1.5 mL/15 min) (Table). There were no significant differences in the 
percentage of decreased salivation between stimulated and unstimulated conditions. 
 
Relationship between MR imaging and salivary flow rate  
HD grade on MR imaging (Figure 1) was significantly related to both stimulated and 
unstimulated salivary flow rates in parotid and submandibular glands: advanced grades 
corresponded to a greater reduction in salivary flow (Figure 2A, 2B, 2E, 2F). However, there 
was no significant relationship between the MHS stage and the salivary flow rate in either the 
parotid or the submandibular glands in both stimulated and unstimulated conditions (Figure 
2C, 2D, 2G, 2H).  
The AUC for the HD grade was significantly greater in the submandibular gland 
than in the parotid gland both for stimulated (parotid gland: AUC 0.786, 95%CI 0.682–0.889, 
vs. submandibular gland: AUC 0.898, 95%CI 0.827–0.969; P < 0.05, Figure 3A) and for 
unstimulated (parotid gland: AUC 0.675, 95%CI 0.549–0.8, vs. submandibular gland: AUC 
0.813, 95%CI 0.712–0.913; P < 0.01, Figure 3B) salivary flow rates. The best cut-off values 
of the HD grade that showed the highest diagnostic accuracy were grade 3 in the parotid 
gland (stimulated salivary flow rate: sensitivity 0.548, specificity 0.958; unstimulated 
salivary flow rate: sensitivity 0.5, specificity 0.909) and grade 2 in the submandibular gland 
(stimulated salivary flow rate: sensitivity 0.81, specificity 0.875; unstimulated salivary flow 
rate: sensitivity 0.727, specificity 0.773). 
 
Page 9 of 27 Oral Diseases
10 
 
Correlation between salivary gland volume and salivary flow rate  
The respective volumes of the parotid and submandibular glands were significantly correlated 
both with the stimulated (ρ = 0.32 and 0.57) (Figure 4A, 4B) and the unstimulated salivary 
flow rates (ρ = 0.40 and 0.63) (Figure 4C, 4D). These ρ values exhibited a weak correlation 
in the parotid gland, but a moderate correlation in the submandibular gland.  
The AUC for the gland volume was significantly greater in the submandibular gland 
than in the parotid gland both for the stimulated (parotid gland: AUC 0.653, 95%CI 0.518–
0.788, vs. submandibular gland: AUC 0.861, 95%CI 0.766–0.956; P < 0.001, Figure 5A) and 
for unstimulated (parotid gland: AUC 0.645, 95%CI 0.514–0.777, vs. submandibular gland: 
AUC 0.805, 95%CI 0.699–0.911; P < 0.05, Figure 5B) salivary flow rates. The best cut-off 
values of the parotid gland volume that showed the highest diagnostic accuracy were 35.7 
cm
3
 for stimulated (sensitivity 0.667, specificity 0.583) and 27.7 cm
3
 for unstimulated 
(sensitivity 0.364, specificity 0.955) salivary flow rate. The best cut-off values of 
submandibular gland volume were 8.03 cm
3
 for stimulated (sensitivity 0.905, specificity 
0.708) and 4.64 cm
3
 for unstimulated (sensitivity 0.591, specificity 0.955) salivary flow rate. 
 
Interobserver agreement 
The respective kappa values of the HD analysis for the parotid and submandibular glands 
were 0.83 and 0.78. The respective kappa values of the MHS analysis for the parotid and 
submandibular glands were 0.89 and 0.92. The strength of agreement was substantial for HD 
in submandibular glands, excellent for HD in parotid gland, and excellent for MHS in both 
parotid and submandibular glands. 
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Discussion 
1 Relationship between MR imaging and salivary flow rate in patients with SS 
Many patients with SS suffer from xerostomia and a subjective feeling of oral 
dryness because this condition can affect speech, mastication, swallowing, taste acuity, and 
ultimately the quality of life (Sreebny, 2010), based on a severe decrease in salivary flow rate. 
Histopathological features of the disease include lymphocytic infiltration, fat tissue 
infiltration, and destruction of the acinar tissues, which result in the atrophy of salivary 
glands (Bloch et al., 1965; Kohler & Winter, 1985; Manthorpe, 2002). Labial gland biopsy 
features have been shown to correlate closely with hyposalivation as the disease progresses 
(Chisholm & Mason, 1968; Daniels et al., 1979; Daniels, 1984).  
To assess the pathological progression in salivary glands on MR images, we studied 
the HD grade on T1- and fat-suppressed T2-weighted images, as well as the MHS stage on 
MR sialograms, based on prior reports (Izumi et al., 1996; Izumi et al., 1997). We 
demonstrated that the HD grade is significantly related to the salivary flow rate under both 
stimulated and unstimulated conditions, in both parotid and submandibular glands in SS 
patients (Figure 2A, 2B, 2E, 2F); however, there was no significant relationship between the 
MHS stage and stimulated or unstimulated salivary flow rate in either the parotid or 
submandibular glands (Figure 2C, 2D, 2G, 2H). Previous studies found that HD in the 
parotid gland represents histopathological destruction of the acinar tissue and fat tissue 
infiltration, while MHS represents ductal abnormalities (Garrett, 1962; Izumi et al., 1997; 
Niemela et al., 2001). Therefore, HD is considered to be more strongly and directly related to 
the salivary flow rate than MHS, because acinar tissue produces the saliva. Additionally, it 
has been reported that (1) diffusely scattered fat deposition in the parotid gland on MR 
imaging is a characteristic feature in SS patients, but is not present in inflamed parotid glands 
(Izumi et al., 1996); (2) the severity of destruction and fat deposition in SS patients’ parotid 
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glands is associated with the stimulated salivary flow rate using MR imaging and CT (Izumi 
et al., 1997); and (3) the severity of abnormalities on the MR sialogram in SS patients’ 
parotid glands is not associated with the unstimulated salivary flow rate (Niemela et al., 
2001). These reports corroborate our findings that HD in the salivary gland is strongly related 
to the salivary flow rate in accordance with the progress of the disease. 
 
2 Correlation between MR imaging and salivary flow rate in patients with SS: 
Submandibular vs parotid gland  
2-1 HD in MR imaging in submandibular vs parotid glands  
Few studies using MR images to date have focused on changes of the submandibular 
gland with respect to the progress of SS. We recently reported that HD on T1- and 
fat-suppressed T2-weighted MR images has higher specificity in the submandibular gland 
than in the parotid gland in SS patients (Kojima et al., 2017). Consequently, we have deduced 
that such specific changes of the submandibular gland would aid in assessment of SS patients, 
particularly in advanced cases. In the current study, we focused on the relationship between 
MR imaging of the submandibular gland and the salivary flow rate, in comparison with the 
parotid gland. We excluded the sublingual gland in this study because of its low diagnostic 
value based on its smaller volume, greater individual or age differences in the size, and low 
interobserver agreement of the imaging analysis, when compared with the parotid and 
submandibular glands (Sumi et al., 1999; Kojima et al., 2017). To compare the two salivary 
glands and to analyse which imaging features were superior for evaluating decreases in the 
salivary flow rate, we used ROC curve analysis which allows comparison of the diagnostic 
performance in a multiple examinations (Griner et al., 1981). Using this method, we have 
demonstrated that HD is more sensitive in the submandibular gland than in the parotid gland 
with respect to hyposalivation, both in stimulated and unstimulated conditions in SS patients 
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(Figure 3A, 3B). The reason that HD was more closely related with salivary flow rate in the 
submandibular gland, compared with the parotid gland, could be attributed to two factors. 
The first factor relates to a physiological aspect. Spontaneous salivary flow derived mainly 
from the submandibular gland, and less often from the parotid gland in the unstimulated 
condition (Aung et al., 2001), i.e., more than 65% of unstimulated saliva is secreted by the 
submandibular gland (Sreebny, 2010). These reports are consistent with our findings. The 
second factor is a pathological aspect. It has been demonstrated that the submandibular gland 
is further impaired than the parotid gland upon evaluation of scintigraphic parameters in SS 
patients, which is accompanied by hyposalivation in the unstimulated condition (Dugonjic et 
al., 2014). Many studies using salivary scintigraphy under lemon stimulation condition also 
demonstrated that the function of the submandibular gland was more impaired than that of the 
parotid gland in SS patients (Umehara et al., 1999; Aung et al., 2000; Tonami et al., 2001; 
Aksoy et al., 2012). Aung et al. and Umehara et al. indicated that tracer accumulation 
decreased more in the submandibular gland, compared with the parotid gland, in SS patients 
(Umehara et al., 1999; Aung et al., 2000). Additionally, Tonami et al. and Aksoy et al., using 
salivary scintigraphy, concluded that the submandibular gland became more impaired than 
the parotid gland with disease progression (Tonami et al., 2001; Aksoy et al., 2012). These 
scintigraphy findings prompt the conclusion that MR imaging can more accurately depict a 
decrease in the salivary flow rate in the submandibular gland, compared with the parotid 
gland, both for unstimulated and stimulated conditions in SS patients. 
 
2-2 Changes in volume on MR imaging in submandibular vs parotid glands  
This study has shown that the parotid and the submandibular glands volume is 
significantly correlated with the stimulated and unstimulated salivary flow rates (Figure 
4A-D) in SS patients. Characteristic MR imaging features in SS patients are atrophy and 
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swelling of the salivary glands, and HD and MHS (Vogl et al., 1996). Swelling of the glands 
is caused by autoimmune inflammation, and shrunken glands are frequently observed on MR 
images as a result of severe atrophic change caused by continuous chronic inflammation 
(Figure 1). The parotid and submandibular gland volume correlates with the stimulated and 
unstimulated salivary flow rate in healthy humans (Ericson et al., 1972; Dawes et al., 1978; 
Ono et al., 2006). Taking these reports into account, it is reasonable to assume that the acinar 
tissue volume observed on MR imaging correlates with the salivary flow rate. We also 
demonstrated that the submandibular gland volume measured on MR imaging was more 
significantly correlated with the stimulated and unstimulated salivary flow rate than the 
parotid gland volume, as compared by ROC curve analysis (Figure 5A, 5B). MR images 
have shown that the parotid gland in SS patients reveals atrophy and swelling, whereas in the 
submandibular gland, atrophy is the dominant feature, rather than swelling (Vogl et al., 1996; 
Kojima et al., 2017). Taken together, we believe that our results indicate that a smaller 
submandibular gland volume is an aid in predicting hyposalivation in patients with SS as the 
disease progresses. 
 
3 Limitations of the study and future research 
We have demonstrated that MR imaging of HD and the volume of the submandibular 
gland can predict a decrease in the salivary flow rate, which is a distressing symptom for 
patients with SS. To clarify the precise relationship between MR imaging and the progression 
of the disease, histopathological evaluation including the measurement of acinar tissue and 
fat deposition should be undertaken by salivary gland biopsy. Histopathological and 
molecular studies are also needed to clarify the mechanism by which the submandibular 
glands are more severely impaired.  
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Conclusions 
We have demonstrated by MR imaging that heterogeneity and a smaller volume of the 
submandibular gland are reliable features for predicting hyposalivation associated with 
progression of SS in patients with the disease. 
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Figure Legends 
Figure 1. Grade of heterogeneous signal-intensity distribution on T1- and fat-suppressed 
T2-weighted images in the parotid and submandibular glands. Grade 0 (definitely normal: 
homogeneous), Grade 1 (probably normal: almost homogeneous), Grade 2 (probably 
abnormal: slight heterogeneous), Grade 3 (clearly abnormal: moderate heterogeneous), Grade 
4 (definitely abnormal: severe heterogeneous). As the grade advances, the area of acinar 
tissue destruction with fat tissue infiltration expands in the parotid or submandibular gland: 
fat infiltration is observed as a very high signal-intensity area on T1-weighted images and as 
a very low signal-intensity area on fat-suppressed T2-weighed images. Severely atrophied 
submandibular gland (arrow heads) and parotid gland (almost displaced by fat tissue) were 
assessed as grade 4. 
 
Figure 2. Relationship between MR imaging and salivary flow rate. The HD grade vs the 
stimulated salivary flow rate in the parotid (A) and submandibular (B) glands. The MHS 
stage vs the stimulated salivary flow rate in the parotid (C) and submandibular (D) glands. 
The HD grade vs the unstimulated salivary flow rate in the parotid (E) and submandibular (F) 
glands. The MHS stage vs the unstimulated salivary flow rate in the parotid (G) and 
submandibular (H) glands. HD = heterogeneous signal-intensity distribution; MHS = multiple 
high signal-intensity spots. Kruskal-Wallis rank sum test and Steel-Dwass method: * P < 0.05, 
** P < 0.01, *** P < 0.001. 
 
Figure 3. ROC curve analysis of HD between the parotid and submandibular glands, for the 
stimulated (A) and unstimulated (B) salivary flow rate. Black and white points show cut-off 
points. HD = heterogeneous signal-intensity distribution; PG = parotid gland; 
SMG = submandibular gland; ROC = receiver operating characteristic. Difference in the area 
under the ROC curve between the parotid and the submandibular glands: * P < 0.05, ** 
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P < 0.01. 
 
Figure 4. Correlation between salivary gland volume and salivary flow rate. The correlation 
between the parotid gland volume and the stimulated salivary flow rate (A), the 
submandibular gland volume and the stimulated salivary flow rate (B), the parotid gland 
volume and the unstimulated salivary flow rate (C), and the submandibular gland volume and 
the unstimulated salivary flow rate (D). Spearman’s rank correlation coefficient (ρ) test: ** P 
< 0.01, *** P < 0.001. 
 
Figure 5. ROC curve analysis of salivary gland volume between the parotid and 
submandibular glands for the stimulated (A) and unstimulated (B) salivary flow rate. Black 
and white points show cut-off points. PG = parotid gland; SMG = submandibular gland; 
ROC = receiver operating characteristic. Difference in the area under the ROC curve between 
the parotid and submandibular glands: * P < 0.05, *** P < 0.001. 
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Table. Salivary flow rate and MR imaging 
 
  
Stimulated 
salivary flow rate 
(cut off: 10 mL/10 min) 
Unstimulated 
salivary flow rate 
(cut off: 1.5 mL/15 min) 
Normal 24 22 
Abnormal 
(hyposalivation) 
42 44 
 
  HD in PG HD in SMG MHS in PG MHS in SMG 
Grade/Stage 0 7 21 23 54 
Grade/Stage 1 15 8 15 7 
Grade/Stage 2 20 17 21 3 
Grade/Stage 3 17 11 7 2 
Grade/Stage 4 7 9 0 0 
 
HD = heterogeneous signal-intensity distribution; MHS = multiple high signal-intensity 
spots; PG = parotid gland; SMG = submandibular gland. 
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Figure 1. Grade of heterogeneous signal-intensity distribution on T1- and fat-suppressed T2-weighted 
images in the parotid and submandibular glands. Grade 0 (definitely normal: homogeneous), Grade 1 
(probably normal: almost homogeneous), Grade 2 (probably abnormal: slight heterogeneous), Grade 3 
(clearly abnormal: moderate heterogeneous), Grade 4 (definitely abnormal: severe heterogeneous). As the 
grade advances, the area of acinar tissue destruction with fat tissue infiltration expands in the parotid or 
submandibular gland: fat infiltration is observed as a very high signal-intensity area on T1-weighted images 
and as a very low signal-intensity area on fat-suppressed T2-weighed images. Severely atrophied 
submandibular gland (arrow heads) and parotid gland (almost displaced by fat tissue) were assessed as 
grade 4.  
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Figure 2. Relationship between MR imaging and salivary flow rate. The HD grade vs the stimulated salivary 
flow rate in the parotid (A) and submandibular (B) glands. The MHS stage vs the stimulated salivary flow 
rate in the parotid (C) and submandibular (D) glands. The HD grade vs the unstimulated salivary flow rate in 
the parotid (E) and submandibular (F) glands. The MHS stage vs the unstimulated salivary flow rate in the 
parotid (G) and submandibular (H) glands. HD = heterogeneous signal-intensity distribution; MHS = 
multiple high signal-intensity spots. Kruskal-Wallis rank sum test and Steel-Dwass method: * P < 0.05, ** P 
< 0.01, *** P < 0.001.  
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Figure 3. ROC curve analysis of HD between the parotid and submandibular glands, for the stimulated (A) 
and unstimulated (B) salivary flow rate. Black and white points show cut-off points. HD = heterogeneous 
signal-intensity distribution; PG = parotid gland; SMG = submandibular gland; ROC = receiver operating 
characteristic. Difference in the area under the ROC curve between the parotid and the submandibular 
glands: * P < 0.05, ** P < 0.01.  
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Figure 4. Correlation between salivary gland volume and salivary flow rate. The correlation between the 
parotid gland volume and the stimulated salivary flow rate (A), the submandibular gland volume and the 
stimulated salivary flow rate (B), the parotid gland volume and the unstimulated salivary flow rate (C), and 
the submandibular gland volume and the unstimulated salivary flow rate (D). Spearman’s rank correlation 
coefficient (ρ) test: ** P < 0.01, *** P < 0.001.  
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Figure 5. ROC curve analysis of salivary gland volume between the parotid and submandibular glands for the 
stimulated (A) and unstimulated (B) salivary flow rate. Black and white points show cut-off points. PG = 
parotid gland; SMG = submandibular gland; ROC = receiver operating characteristic. Difference in the area 
under the ROC curve between the parotid and submandibular glands: * P < 0.05, *** P < 0.001.  
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STROBE Statement—checklist of items that should be included in reports of observational studies 
 
 Item 
No Recommendation 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract 
(b) Provide in the abstract an informative and balanced summary of what was done 
and what was found 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported 
Objectives 3 State specific objectives, including any prespecified hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, 
exposure, follow-up, and data collection 
Participants 6 (a) Cohort study—Give the eligibility criteria, and the sources and methods of 
selection of participants. Describe methods of follow-up 
Case-control study—Give the eligibility criteria, and the sources and methods of 
case ascertainment and control selection. Give the rationale for the choice of cases 
and controls 
Cross-sectional study—Give the eligibility criteria, and the sources and methods of 
selection of participants 
(b) Cohort study—For matched studies, give matching criteria and number of 
exposed and unexposed 
Case-control study—For matched studies, give matching criteria and the number of 
controls per case 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect 
modifiers. Give diagnostic criteria, if applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of 
assessment (measurement). Describe comparability of assessment methods if there 
is more than one group 
Bias 9 Describe any efforts to address potential sources of bias 
Study size 10 Explain how the study size was arrived at 
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, 
describe which groupings were chosen and why 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding 
(b) Describe any methods used to examine subgroups and interactions 
(c) Explain how missing data were addressed 
(d) Cohort study—If applicable, explain how loss to follow-up was addressed 
Case-control study—If applicable, explain how matching of cases and controls was 
addressed 
Cross-sectional study—If applicable, describe analytical methods taking account of 
sampling strategy 
(e) Describe any sensitivity analyses 
Continued on next page
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Results 
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, 
examined for eligibility, confirmed eligible, included in the study, completing follow-up, and 
analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
Descriptive 
data 
14* (a) Give characteristics of study participants (eg demographic, clinical, social) and information 
on exposures and potential confounders 
(b) Indicate number of participants with missing data for each variable of interest 
(c) Cohort study—Summarise follow-up time (eg, average and total amount) 
Outcome data 15* Cohort study—Report numbers of outcome events or summary measures over time 
Case-control study—Report numbers in each exposure category, or summary measures of 
exposure 
Cross-sectional study—Report numbers of outcome events or summary measures 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their 
precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and 
why they were included 
(b) Report category boundaries when continuous variables were categorized 
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful 
time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity 
analyses 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. 
Discuss both direction and magnitude of any potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity 
of analyses, results from similar studies, and other relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, 
for the original study on which the present article is based 
 
*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and 
unexposed groups in cohort and cross-sectional studies. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and 
published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely 
available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at 
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is 
available at www.strobe-statement.org. 
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